ZDHHC16 restrains osteogenic differentiation of bone marrow mesenchymal stem cells by inhibiting phosphorylation of CREB.
ZDHHC16 restrains osteogenic differentiation of bone marrow mesenchymal stem cells by inhibiting phosphorylation of CREB.
复制标题
DOI:
10.1016/j.heliyon.2022.e12788
复制
发表时间:
2023-01
期刊:
影响因子:
4
通讯作者:
Zhang, Chao
中科院分区:
文献类型:
--
作者:
Li, Zhiwei;Cheng, Yuan;Jin, Xiangyun;Liu, Shenghe;Zhang, Chao
The osteogenesis of human bone marrow mesenchymal stem cells (hBMSCs) plays a critical role in fracture healing. Osteogenic differentiation is regulated by a variety of post-translational modifications, but the function of protein palmitoylation in osteogenesis remains largely unknown. Osteogenic differentiation induction of hBMSCs was used in this study. RT‒qPCR and immunoblotting assays (WB) were used to test marker genes of osteogenic induction. Alkaline phosphatase (ALP) activity, ALP staining and Alizarin red staining were performed to evaluate osteogenesis of hBMSCs. Signal finder pathway reporter array, co-immunoprecipitation and WB were applied to elucidate the molecular mechanism. A mouse fracture model was used to verify the in vivo function of the ZDHHC inhibitor. We revealed that palmitic acid inhibited Runx2 mRNA expression in hBMSCs and identified ZDHHC16 as a potential target palmitoyl acyltransferase. In addition, ZDHHC16 decreased during osteogenic induction. Next, we confirmed the inhibitory function of ZDHHC16 by its knockdown or overexpression during osteogenesis of hBMSCs. Moreover, we illustrated that ZDHHC16 inhibited the phosphorylation of CREB, thus inhibiting osteogenesis of hBMSCs by enhancing the palmitoylation of CREB. With a mouse femur fracture model, we found that 2-BP, a general inhibitor of ZDHHCs, promoted fracture healing in vivo. Thus, we clarified the inhibitory function of ZDHHC16 during osteogenic differentiation. Collectively, these findings highlight the inhibitory function of ZDHHC16 in osteogenesis as a potential therapy method for fracture healing.
登录
查看更多内容
影响因子:
5.2
作者:
Granero-Molto, Froilan;Myers, Timothy J.;Weis, Jared A.;Longobardi, Lara;Li, Tieshi;Yan, Yun;Case, Natasha;Rubin, Janet;Spagnoli, Anna
通讯作者:
Spagnoli, Anna
DOI:
10.1007/978-1-4939-9532-5_16
发表时间:
2019-01-01
期刊:
PROTEIN LIPIDATION: METHODS AND PROTOCOLS
影响因子:
--
作者:
Blanc, Mathieu;David, Fabrice P. A.;van der Goot, F. Gisou
通讯作者:
van der Goot, F. Gisou
DOI:
10.26355/eurrev_201712_13990
发表时间:
2017-12-01
影响因子:
3.3
作者:
Dong, C. -H.;Deng, Y. -S.;Zhen, P.
通讯作者:
Zhen, P.
DOI:
10.1038/nrrheum.2014.164
发表时间:
2015-01
期刊:
Nature reviews. Rheumatology
影响因子:
--
作者:
通讯作者:
--
影响因子:
64.5
作者:
Fiddes IT;Lodewijk GA;Mooring M;Bosworth CM;Ewing AD;Mantalas GL;Novak AM;van den Bout A;Bishara A;Rosenkrantz JL;Lorig-Roach R;Field AR;Haeussler M;Russo L;Bhaduri A;Nowakowski TJ;Pollen AA;Dougherty ML;Nuttle X;Addor MC;Zwolinski S;Katzman S;Kriegstein A;Eichler EE;Salama SR;Jacobs FMJ;Haussler D
通讯作者:
Haussler D